Navidea Biopharmaceuticals PE Ratio 2006-2020 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of August 13, 2020 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2020-08-13 | 3.17 | 0.00 | |
| 2020-03-31 | 0.76 | $-0.69 | 0.00 |
| 2019-12-31 | 1.26 | $-0.80 | 0.00 |
| 2019-09-30 | 0.69 | $-1.05 | 0.00 |
| 2019-06-30 | 0.63 | $-1.28 | 0.00 |
| 2019-03-31 | 0.14 | $-1.44 | 0.00 |
| 2018-12-31 | 0.10 | $-2.00 | 0.00 |
| 2018-09-30 | 0.23 | $-2.20 | 0.00 |
| 2018-06-30 | 0.23 | $-2.00 | 0.00 |
| 2018-03-31 | 0.36 | $-2.20 | 0.00 |
| 2017-12-31 | 0.36 | $9.00 | 0.04 |
| 2017-09-30 | 0.42 | $9.20 | 0.05 |
| 2017-06-30 | 0.51 | $9.40 | 0.05 |
| 2017-03-31 | 0.58 | $9.20 | 0.06 |
| 2016-12-31 | 0.64 | $-1.60 | 0.00 |
| 2016-09-30 | 0.92 | $-1.60 | 0.00 |
| 2016-06-30 | 0.53 | $-2.60 | 0.00 |
| 2016-03-31 | 0.94 | $-3.00 | 0.00 |
| 2015-12-31 | 1.33 | $-3.60 | 0.00 |
| 2015-09-30 | 2.28 | $-4.20 | 0.00 |
| 2015-06-30 | 1.61 | $-4.20 | 0.00 |
| 2015-03-31 | 1.59 | $-4.40 | 0.00 |
| 2014-12-31 | 1.89 | $-5.00 | 0.00 |
| 2014-09-30 | 1.32 | $-6.00 | 0.00 |
| 2014-06-30 | 1.48 | $-6.80 | 0.00 |
| 2014-03-31 | 1.85 | $-7.20 | 0.00 |
| 2013-12-31 | 2.07 | $-6.80 | 0.00 |
| 2013-09-30 | 2.65 | $-6.20 | 0.00 |
| 2013-06-30 | 2.67 | $-6.20 | 0.00 |
| 2013-03-31 | 2.71 | $-5.60 | 0.00 |
| 2012-12-31 | 2.83 | $-5.80 | 0.00 |
| 2012-09-30 | 2.75 | $-6.00 | 0.00 |
| 2012-06-30 | 3.72 | $0.00 | 0.00 |
| 2012-03-31 | 3.28 | $0.80 | 4.10 |
| 2011-12-31 | 2.62 | $1.20 | 2.18 |
| 2011-09-30 | 2.96 | $2.20 | 1.35 |
| 2011-06-30 | 3.32 | $-2.60 | 0.00 |
| 2011-03-31 | 3.95 | $-15.00 | 0.00 |
| 2010-12-31 | 2.06 | $-14.60 | 0.00 |
| 2010-09-30 | 1.88 | $-14.00 | 0.00 |
| 2010-06-30 | 1.80 | $-20.20 | 0.00 |
| 2010-03-31 | 1.64 | $-11.60 | 0.00 |
| 2009-12-31 | 1.22 | $-10.80 | 0.00 |
| 2009-09-30 | 1.40 | $-11.20 | 0.00 |
| 2009-06-30 | 0.95 | $-5.00 | 0.00 |
| 2009-03-31 | 0.54 | $-1.00 | 0.00 |
| 2008-12-31 | 0.57 | $-1.60 | 0.00 |
| 2008-09-30 | 0.57 | $-1.80 | 0.00 |
| 2008-06-30 | 0.68 | $-1.40 | 0.00 |
| 2008-03-31 | 0.35 | $-1.60 | 0.00 |
| 2007-12-31 | 0.29 | $-1.60 | 0.00 |
| 2007-09-30 | 0.31 | $-1.40 | 0.00 |
| 2007-06-30 | 0.27 | $-1.80 | 0.00 |
| 2007-03-31 | 0.24 | $-1.60 | 0.00 |
| 2006-12-31 | 0.24 | $-1.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.082B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $164.803B | 31.28 |
| Intuitive Surgical (ISRG) | United States | $80.813B | 72.61 |
| Edwards Lifesciences (EW) | United States | $49.366B | 44.11 |
| DexCom (DXCM) | United States | $41.675B | 143.66 |
| IDEXX Laboratories (IDXX) | United States | $32.767B | 72.83 |
| ALCON INC (ALC) | Switzerland | $30.249B | 33.86 |
| Olympus (OCPNY) | Japan | $27.569B | 71.82 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $25.746B | 16.60 |
| Teleflex (TFX) | United States | $17.774B | 35.06 |
| Hologic (HOLX) | United States | $17.642B | 26.40 |
| Sysmex ADR (SSMXY) | Japan | $16.370B | 46.14 |
| Varian Medical Systems (VAR) | United States | $15.756B | 43.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.326B | 0.00 |
| ABIOMED (ABMD) | United States | $13.891B | 82.89 |
| STERIS (STE) | Ireland | $13.540B | 27.83 |
| Masimo (MASI) | United States | $11.756B | 61.30 |
| SARTORIUS AG (SARTF) | Germany | $10.725B | 92.21 |
| Penumbra (PEN) | United States | $8.620B | 1404.29 |
| Tandem Diabetes Care (TNDM) | United States | $5.963B | 0.00 |
| Globus Medical (GMED) | United States | $5.379B | 43.08 |
| Nevro (NVRO) | United States | $4.741B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $4.359B | 23.83 |
| Elekta AB (EKTAY) | Sweden | $4.290B | 33.03 |
| Wright Medical Group (WMGI) | Netherlands | $3.904B | 0.00 |
| OPKO Health (OPK) | United States | $3.252B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.972B | 30.09 |
| LivaNova (LIVN) | United Kingdom | $2.364B | 24.05 |
| Cantel Medical (CMD) | United States | $2.313B | 26.77 |
| Integer Holdings (ITGR) | United States | $2.296B | 17.40 |
| Glaukos (GKOS) | United States | $1.896B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.854B | 0.00 |
| Veracyte (VCYT) | United States | $1.761B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.638B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.576B | 35.42 |
| Luminex (LMNX) | United States | $1.481B | 138.87 |
| Mesa Laboratories (MLAB) | United States | $1.263B | 62.31 |
| GenMark Diagnostics (GNMK) | United States | $1.134B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $1.060B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.866B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.838B | 0.00 |
| CryoLife (CRY) | United States | $0.807B | 355.17 |
| Tactile Systems Technology (TCMD) | United States | $0.741B | 636.33 |
| Inogen (INGN) | United States | $0.717B | 75.56 |
| Intersect ENT (XENT) | United States | $0.678B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.654B | 81.12 |
| Si-Bone (SIBN) | United States | $0.617B | 0.00 |
| Natus Medical (NTUS) | United States | $0.597B | 24.16 |
| Fluidigm (FLDM) | United States | $0.567B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.508B | 0.00 |
| TransMedics (TMDX) | United States | $0.497B | 0.00 |
| ViewRay (VRAY) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.466B | 0.00 |
| Repro Med Systems (KRMD) | United States | $0.434B | 197.80 |
| Vermillion (AWH) | United States | $0.394B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.388B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.381B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.362B | 106.33 |
| Semler Scientific (SMLR) | United States | $0.328B | 42.02 |
| Stereotaxis (STXS) | United States | $0.278B | 0.00 |
| IRadimed (IRMD) | United States | $0.270B | 51.23 |
| Accuray (ARAY) | United States | $0.245B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.235B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.199B | 0.00 |
| Sientra (SIEN) | United States | $0.191B | 0.00 |
| Electromed (ELMD) | United States | $0.148B | 37.83 |
| EDAP TMS S.A (EDAP) | France | $0.096B | 47.29 |
| Restoration Robotics (VERO) | Canada | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.093B | 0.00 |
| Neuronetics (STIM) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.062B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.061B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.060B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.057B | 0.00 |
| ConforMIS (CFMS) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.051B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.050B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.048B | 0.00 |
| TransEnterix (TRXC) | United States | $0.042B | 0.00 |
| Neovasc (NVCN) | Canada | $0.039B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.037B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.036B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.033B | 0.00 |
| Avinger (AVGR) | United States | $0.030B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.025B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.024B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.021B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.020B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.014B | 0.00 |
| InspireMD (NSPR) | Israel | $0.014B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.013B | 45.40 |
| Dynatronics (DYNT) | United States | $0.011B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.009B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.007B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.006B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.004B | 0.00 |
